Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caio Bezerra Machado

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biomedicines|May 16, 2023
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid LeukemiaFlávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Igor Valentim Barreto, et al.
Cancer Diagnosis & Prognosis|January 4, 2024
Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for LeukemiasAnna Karolyna DA Costa Machado, Caio Bezerra Machado, Flávia Melo Cunha DE Pinho Pessoa, et al.
Frontiers in Oncology|July 11, 2022
Leukemic Stem Cell: A Mini-Review on Clinical PerspectivesIgor Valentim Barreto, Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, et al.
International Journal of Molecular Sciences|July 28, 2022
Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising BiomarkersAna Beatriz Aguiar Sanford, Leidivan Sousa da Cunha, Caio Bezerra Machado, et al.
Pharmaceutics|September 23, 2022
Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical PerspectivesIgor Valentim Barreto, Caio Bezerra Machado, Davi Benevides Almeida, et al.
Cancer Reports (Hoboken, N.J.)|February 9, 2026
WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT ExpressionRenan Brito Gadelha, Beatriz Maria Dias Nogueira, Caio Bezerra Machado, et al.
Cancer Diagnosis & Prognosis|September 6, 2024
Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With <i>BCR::ABL1 p190+</i> TranslocationGuilherme Passos DE Morais, Caio Bezerra Machado, Beatriz Maria Dias Nogueira, et al.
Biomedicines|November 27, 2025
Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic VariantsFlávia Melo Cunha de Pinho Pessoa, Isabelle Magalhães Farias, Beatriz Maria Dias Nogueira, et al.
Anticancer Research|May 31, 2024
Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia PatientsFlávia Melo Cunha DE Pinho Pessoa, Deivide DE Sousa Oliveira, Beatriz Maria Dias Nogueira, et al.
In Vivo (Athens, Greece)|June 27, 2024
Molecular and Clinical Insights in the Increasing Detection of <i>BCR::ABL1 p190+</i> in Adult Acute Myeloid Leukemia PatientsFlávia Melo Cunha DE Pinho Pessoa, Beatriz Maria Dias Nogueira, Caio Bezerra Machado, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biomedicines|May 16, 2023
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid LeukemiaFlávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Igor Valentim Barreto, et al.
Cancer Diagnosis & Prognosis|January 4, 2024
Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for LeukemiasAnna Karolyna DA Costa Machado, Caio Bezerra Machado, Flávia Melo Cunha DE Pinho Pessoa, et al.
Frontiers in Oncology|July 11, 2022
Leukemic Stem Cell: A Mini-Review on Clinical PerspectivesIgor Valentim Barreto, Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, et al.
International Journal of Molecular Sciences|July 28, 2022
Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising BiomarkersAna Beatriz Aguiar Sanford, Leidivan Sousa da Cunha, Caio Bezerra Machado, et al.
Pharmaceutics|September 23, 2022
Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical PerspectivesIgor Valentim Barreto, Caio Bezerra Machado, Davi Benevides Almeida, et al.
Cancer Reports (Hoboken, N.J.)|February 9, 2026
WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT ExpressionRenan Brito Gadelha, Beatriz Maria Dias Nogueira, Caio Bezerra Machado, et al.
Cancer Diagnosis & Prognosis|September 6, 2024
Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With <i>BCR::ABL1 p190+</i> TranslocationGuilherme Passos DE Morais, Caio Bezerra Machado, Beatriz Maria Dias Nogueira, et al.
Biomedicines|November 27, 2025
Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic VariantsFlávia Melo Cunha de Pinho Pessoa, Isabelle Magalhães Farias, Beatriz Maria Dias Nogueira, et al.
Anticancer Research|May 31, 2024
Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia PatientsFlávia Melo Cunha DE Pinho Pessoa, Deivide DE Sousa Oliveira, Beatriz Maria Dias Nogueira, et al.
In Vivo (Athens, Greece)|June 27, 2024
Molecular and Clinical Insights in the Increasing Detection of <i>BCR::ABL1 p190+</i> in Adult Acute Myeloid Leukemia PatientsFlávia Melo Cunha DE Pinho Pessoa, Beatriz Maria Dias Nogueira, Caio Bezerra Machado, et al.
Pageof 3